PALYNZIQ (PEGVALIASE-PQPZ) — FDA Approval BLA761079 (BIOMARIN PHARM)
PALYNZIQ (PEGVALIASE-PQPZ) — FDA Approval BLA761079 (BIOMARIN PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PALYNZIQ; Active ingredients: PEGVALIASE-PQPZ; Application number: BLA761079.
| Brand name | PALYNZIQ |
|---|---|
| Active ingredients | PEGVALIASE-PQPZ |
| Application number | BLA761079 |
| Sponsor | BIOMARIN PHARM |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20180524 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →